Hjem
Elise Aasebøs bilde

Elise Aasebø

Postdoktor
  • E-postElise.Aasebo@uib.no
  • Telefon+47 456 66 068
  • Besøksadresse
    BB-bygget
    Jonas Lies vei 91
    Rom 
    6C131cA
  • Postadresse
    Postboks 7804
    5020 Bergen

Bruker metoder innenfor massespektrometribasert kvantitativ proteomikk for å analysere leukemiceller fra pasienter med akutt myelogen leukemi (AML).

Prosjektet har som mål å finne prognostiske biomarkører som kan bidra til en mer tilpasset behandling av AML-pasienter. 

 

 

 

Vitenskapelig artikkel
  • Vis forfatter(e) (2019). Proteomic profiling of primary human acute myeloid leukemia cells does not reflect their constitutive release of soluble mediators. Proteomes. 1-10.
  • Vis forfatter(e) (2018). Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic and transcriptomic comparison. Expert opinion on therapeutic targets. 639-653.
  • Vis forfatter(e) (2017). Phosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemia. Journal of Proteomics. 32-41.
  • Vis forfatter(e) (2016). Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients. Biological Procedures Online. 1-10.
  • Vis forfatter(e) (2016). Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Proteomics. 1154-1165.
  • Vis forfatter(e) (2016). Global cell proteome profiling, phospho-signaling and quantitative proteomics for identification of new biomarkers in acute myeloid leukemia patients. Current Pharmaceutical Biotechnology. 52-70.
  • Vis forfatter(e) (2016). Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows. Journal of Proteomics. 214-225.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2019). An overview on G protein-coupled receptor-induced signal transduction in acute myeloid leukemia. Current Medicinal Chemistry. 5293-5316.
  • Vis forfatter(e) (2018). Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia. Expert Review of Hematology. 13-24.
  • Vis forfatter(e) (2017). Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies. Expert Opinion on Drug Discovery. 1053-1065.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper